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ABSTRACT Models for the binding of the 200-residue carboxy-terminal domain of two mutants of apolipoprotein A-I (apo
A-I), apo A-I(R173C)Milano and apo A-I(R151C)Paris, to lipid in discoidal high-density lipoprotein (HDL) particles are presented.
In both models, two monomers of the mutant apo A-I molecule bind to lipid in an antiparallel manner, with the long axes of
their helical repeats running perpendicular to the normal of the lipid bilayer to form a single disulfide-linked homodimer. The
overall structures of the models of these two mutants are very similar, differing only in helix-helix registration. Thus these
models are consistent with experimental observations that reconstituted HDL particles containing apo A-IMilano and apo
A-IParis are very similar in diameter to reconstituted HDL particles containing wild-type apo A-I, and they support the belief
that apo A-I binds to lipid in discoidal HDL particles via the belt conformation.
INTRODUCTION
Apolipoprotein A-I (apo A-I) is the primary protein com-
ponent of high-density lipoprotein (HDL) particles. The
structure of apo A-I has been a subject of intense study
because elevated levels of HDL correlate strongly with a
reduced risk for atherosclerosis (Miller and Miller, 1975;
Miller et al., 1977; Castelli et al., 1986). In addition to its
ability to solubilize lipid, apo A-I serves as the major
activator of lecithin cholesterol acyltransferase (LCAT) and
promotes cellular cholesterol efflux (Rothblat et al., 1992).
Apo A-I is a major constituent of both spherical and
nascent discoidal HDL particles. The size of both spherical
and discoidal HDL particles is heterogeneous, with diame-
ters ranging from 7 to 13 nm (Atkinson et al., 1974; Brouil-
lette and Anantharamaiah, 1995). The smallest discoidal
particles contain two monomers of apo A-I per HDL parti-
cle (Jonas et al., 1990). The 200-residue carboxy-terminal
lipid-binding domain of apo A-I is characterized by eight
22-mer and two 11-mer repeats defined by the presence of
proline residues at the beginning of most repeats. The se-
quence of these repeats is characteristic of that of an am-
phipathic -helix (Segrest et al., 1974, 1992).
There are two prevailing models of the structure of apo
A-I in discoidal HDL particles. In the picket fence model,
the lipid-binding domain, made up of 8–10 short antiparal-
lel helices, runs along the circumference of the disc with its
hydrophobic face oriented toward the interior of the disc
and the long axes of the helices parallel to the normal of the
lipid bilayer (Tall et al., 1977; Nolte and Atkinson, 1992;
Phillips et al., 1997). In the belt model, long continuous
antiparallel amphipathic helices of the lipid-binding domain
are arranged on the exterior of the disc with their hydro-
phobic faces curved toward the center of the disk and the
long axes of the helices perpendicular to the normal of the
lipid bilayer (Segrest, 1977, 1999; Borhani et al., 1997;
Rogers et al., 1998; Koppaka et al., 1999).
An amino-terminal mutant of human apo A-I, apo (1–
43) A-I, in which the first 43 residues were deleted, has
been reported previously (Rogers et al., 1997). Studies of
apo (1–43) A-I have shown this mutant to be very similar
to wild-type apo A-I in lipid association with 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) vesicles and
activation of LCAT activity. Wild-type apo A-I and apo
(1–43) A-I have similar  helical composition when
bound to lipid (80%). Interestingly, unlike wild-type apo
A-I, there is no statistically significant difference in the
-helicity for apo (1–43) A-I between its lipid-free and
lipid-bound conformations (Rogers et al., 1997). These re-
sults suggested that the structure of lipid-free apo (1–43)
A-I was similar to that of lipid-bound wild-type apo A-I. In
the crystal structure of human apo (1–43) A-I, residues
44–243 formed a continuous amphipathic -helix. Two
monomers of apo A-I associated with each other in an
antiparallel manner in the crystal structure to form a dimer.
The authors explained why the crystal structure supports the
belief that apo A-I binds to lipid via the belt model (Borhani
et al., 1997).
Earlier we proposed a detailed model for the binding of
apo A-I to lipid in discoidal HDL particles in the belt
conformation (Segrest et al., 1999). In this model, two
monomers of apo A-I run around the edges of the lipid
bilayer in an antiparallel fashion. Although the binding of
apo A-I to lipid is driven by hydrophobic interactions, these
interactions are nonspecific. In the belt model interhelical
salt bridging plays a role in determining the specificity of
helix-helix registration. The salt bridging hypothesis of the
belt model is supported by evidence from a molecular
dynamics simulation on a model HDL particle containing
POPC and a model peptide (Sheldahl and Harvey, 1999).
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This molecular dynamics simulation showed that interheli-
cal energetics were dominated by the formation of salt
bridges, and the authors predicted that interhelical salt
bridging was likely to play a role in determining helix-helix
registration in belt models.
Two antiparallel amphipathic -helices can interact with
one another through either of two interfaces. Interhelical salt
bridges could determine the preference for one antiparallel
interface and could dictate the registration of the helices.
This hypothesis is supported by our analysis of all possible
helix-helix alignments in alternative belt models, in which
we found that the model with maximum salt bridging cor-
responded to the alignment found in the apo (1–43) A-I
crystal structure (Segrest et al., 1999).
Two naturally occurring human mutations of apolipopro-
tein A-I have been isolated in which an arginine residue is
mutated to cysteine. In apo A-IMilano this substitution occurs
at residue 173, whereas in apo A-IParis this substitution
occurs at residue 151 (Weisgraber et al., 1983; Bruckert et
al., 1997). These mutations are interesting because wild-
type apo A-I does not contain any cysteine residues. Re-
constituted HDL particles containing disulfide-linked ho-
modimers of either apo A-IMilano or apo A-IParis were similar
to reconstituted HDL particles containing wild-type apo A-I
in their ability to clear dimyristoylphosphatidylcholine
(DMPC) emulsions and their ability to promote cholesterol
efflux (Calabresi et al., 1997b; Franceschini et al., 1999;
Daum et al., 1999). In both mutations, heterozygous indi-
viduals have decreased levels of HDL but are paradoxically
at a reduced risk for atherosclerosis (Franceschini et al.,
1980; Weisgraber et al., 1983; Bruckert et al., 1997). In
addition, it has been shown that reconstituted HDL particles
containing apo A-IMilano or apo A-IParis are capable of
LCAT activation, although at a decreased efficiency com-
pared to reconstituted HDL particles containing wild-type
apo A-I (Calabresi et al., 1997a; Daum et al., 1999). In
individuals heterozygous for either mutation, HDL particles
containing apo A-IMilano or apo A-IParis form either disul-
fide-linked homodimers of apo A-I or heterodimers of apo
A-I and apo A-II (Weisgraber et al., 1983; Bruckert et al.,
1997). Sirtori et al. (1999) have previously presented a
picket fence model for the binding of apo A-IMilano to
discoidal HDL particles.
Apo A-IMilano forms reconstituted HDL particles with
two distinct diameters containing either two or four mole-
cules of apo A-I present as disulfide linked homodimers.
These reconstituted HDL particles are of a size comparable
to that of reconstituted HDL particles containing wild-type
apo A-I (Calabresi et al., 1997a). Apo A-IParis forms recon-
stituted HDL particles with three distinct diameters. The
majority of the reconstituted HDL particles containing apo
A-IParis were found to have a mean diameter equal to that of
reconstituted HDL particles containing wild-type apo A-I
(Daum et al., 1999). The models for apo A-IMilano and apo
A-IParis presented in this paper represent the smaller sized
particles; they contain two monomers of mutant apo A-I and
present a single disulfide-linked homodimer per reconsti-
tuted HDL particle.
Based upon the belt model for apo A-I published previ-
ously, we have constructed similar models for disulfide-
linked homodimers of apo A-IMilano and apo A-IParis bound
to discoidal HDL particles. We argue that the models pre-
sented for apo A-IMilano and apo A-IParis agree with the
experimental data for the size and shape of reconstituted
HDL particles containing the Paris and Milano mutations.
METHODS
The belt model of apo A-I published previously (Segrest et al., 1999) was
used as a starting structure. Modeling was carried out with the Quanta/
Charmm package (Molecular Simulations, San Diego, CA) on an SGI
Octane workstation. For the apo A-IMilano mutant, Arg
173 on both mono-
mers was mutated to a cysteine. One of the monomers was then rotated
with respect to the other one until Cys173 was directly across from the
corresponding cysteine residue in the other monomer. A disulfide bridge
was then added between the two gamma sulfurs, which were2.0 Å apart.
One hundred cycles of steepest descent energy minimization were then
carried out to eliminate unacceptable steric interactions. The same proce-
dure was then repeated for apo A-IParis, with Arg
151 mutated to a cysteine.
RESULTS
Models for Apo A-I Milano and Paris mutations
Shown in Fig. 1 is a helical wheel diagram of helical repeats
2–9 from the carboxy-terminal lipid-binding domain of apo
A-I. When these amphipathic -helical repeats of apo A-I
are plotted on a helical wheel as an 11/3-helix, the hydro-
phobic face of the resulting 198-residue amphipathic -he-
lix is clearly continuous along one face of the helix (Segrest
et al., 1999). We assume that the transformation of an
idealized -helix to an 11/3-helix would involve some
small energy costs that would be offset by lipid association.
Analysis of the individual 22mer helical domains in apo
A-I, using the 76 algorithm (Palgunachari et al., 1996;
Mishra and Palgunachari, 1996) to calculate affinity, shows
that helices 2–9, individually or together, have a signifi-
cantly greater lipid affinity as 11/3-helices than as ideal-
ized -helices. We hypothesize that this increased affinity
provides more free energy than is required to convert a
standard -helix into the 11/3-helix conformation. In ad-
dition, 76 affinity calculations indicate that the lipid affinity
of helix 10 is largely insensitive to the idealized -helix–
to–11/3-helix transition, and helix 1 prefers the idealized
-helical conformation.
The locations of the arginine-to-cysteine substitutions in
apo A-IMilano and apo A-IParis are particularly striking be-
cause they occur exactly 22 residues from one another in the
amino acid sequence. When the carboxy-terminal domains
of apo A-IMilano and apo A-IParis are plotted on the 11/3-
helix, residues 151 and 173 both fall on position 9 of the
helical wheel. This, combined with the phenotypic similar-
1680 Klon et al.
Biophysical Journal 79(3) 1679–1685
ities of the two mutants, suggests that apo A-IMilano and apo
A-IParis are structurally very similar.
There are two possible orientations in which two mole-
cules of apo A-I can interact with one another in an anti-
parallel manner to form a dimeric belt. We have previously
referred to these two orientations as the LL and RR orien-
tations (Segrest et al., 1999). The LL interface brings the
side chains at positions 2, 5, and 9 of the helical wheel into
position to participate in interhelical salt bridging, and this
is the orientation that is observed in the crystal structure of
human apo (1–43) A-I (Borhani et al., 1997). The LL
alignment is the orientation in which cysteines at position 9
of the helical wheel can be opposed to form a disulfide
bridge. In this orientation, residues at position 9 of the
helical wheel are in the middle of the docking interface,
whereas in the RR orientation, these residues would lie on
opposite sides of the helices and would be unable to interact
with each other. As a result, only the LL interface is favor-
able for the formation of disulfide linked homodimers of
apo A-IMilano or apo A-IParis.
As a consequence of the LL orientation of apo A-I in the
belt model, cysteine residues located at position 9 of the
helical wheel, as they are in both the apo A-IMilano and apo
A-IParis mutations, would be in a better position to form
interhelical disulfide bonds than mutations at positions 2 or
5 on the helical wheel. To make disulfide bridges between
residues at positions 2 or 5 of the helical wheel, the structure
of the belt model would have to be distorted. However,
cysteine can be substituted for arginine at position 9 on the
helical wheel, preserving the 10-Å distance between the
centers of the neighboring helices and providing good cov-
erage of the hydrophobic surface area of the lipid in the
HDL particle.
Fig. 2 is a Ribbons diagram of the belt model for a
disulfide-linked homodimer of apo A-IMilano bound to dis-
coidal HDL particles. The overall structure of the resulting
model is very similar to our previously published belt model
for wild-type apo A-I (Segrest et al., 1999). The hydropho-
bic faces of the helices are oriented toward the center of the
disk to bind lipid, and interhelical interactions in the model
are dominated by salt bridges that form between positions 2
and 2, as well as between positions 5 and 9, and 9 and 5
on the helical wheel (Fig. 1). Also shown in Fig. 2 is the
location of the disulfide bond in the apo A-IMilano ho-
modimer. To form the disulfide bond between the two
molecules of apo A-IMilano in the helix-helix registration
published by Segrest et al., the two monomers simply need
to rotate about the discoidal core until the two cysteine
residues are brought into position to form a covalent bond.
This rotation forces a helix-helix registration that is differ-
ent from the one predicted for wild-type apo A-I in our
previous paper. A similar model has been built for the
structure of a disulfide-linked homodimer of apo A-IParis
(data not shown). Although the overall structure of the belt
model would remain the same, different salt bridges would
be predicted to form between helices in the dimer.
Implications for HDL structure
Fig. 3 depicts an analysis of salt bridging as a function of
helix-helix registration in the LL interface, using a previ-
ously published empirical salt bridge scoring function (Seg-
rest et al., 1999). The wild-type orientation corresponds to
the helix-helix registration observed in the crystal structure
(Borhani et al., 1997). Using an 11/3-helix results in a
FIGURE 1 Helical wheel of helices 2–9 (residues 66–219) of human
apo A-I. This view is down the long axis of the helices from the N-terminal
toward the C-terminal end, with a pitch of 11/3 residues per turn. Helices
are numbered on the concentric circles. Hydrophobic residues are indicated
by solid black circles, acidic residues by solid red circles, basic residues by
solid blue circles, and proline residues by solid green circles. The locations
of the Milano and Paris mutations are indicated by purple circles. This
figure was generated by WHEEL (Jones et al., 1992).
FIGURE 2 Ribbon diagram of a model for a disulfide-linked homodimer
of apo A-IMilano for helices 1–10 (residues 44–241). The location of proline
residues is indicated in green. Only acidic and basic side chains at positions
2, 5, and 9 in the helical wheel are shown. Acidic side chains are in red,
basic side chains in blue, and the location of the cystine disulfide bridge in
yellow. This figure was generated by RIBBONS (Carson, 1997).
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favorable helix-helix interaction as one monomer is rotated
relative to the other at intervals of 11 residues (Segrest et al.,
1999). This periodicity in the weighted salt bridge score is
particularly striking, considering the fact that the cysteine
substitutions in apo A-IMilano and 151 in apo A-IParis are
exactly 22 residues apart. The orientations that bring resi-
dues 173 into position to form a disulfide bond in apo
A-IMilano (and residues 151 in apo A-IParis) are labeled in
Fig. 3. These two orientations also have favorable weighted
salt-bridge scores. Thus the belt model is consistent with
experimental observations that reconstituted HDL particles
containing disulfide-linked homodimers of apo A-IMilano
and apo A-IParis would be structurally very similar to each
other and predicts that these mutants would have favorable
interhelical interactions, based upon their potential to form
salt bridges.
DISCUSSION
If the belt model proposed by Segrest et al. is correct, the
function of interhelical salt bridges in HDL particles is to
provide specificity for helix-helix interactions while adding
little to the overall stability of the protein-lipid complex.
When we use the weighted salt bridge scoring function in
the ALIGN program, the helix-helix registration observed
in the crystal structure of apo (1–43) A-I is the most
favored orientation. Because of the presence of a covalent
bond between two monomers of apo A-I in disulfide-linked
homodimers of apo A-IMilano and apo A-IParis, the helix-
helix registration in the belt model would be locked into
rotational orientations different from that seen in the crystal
structure, effectively forcing the dimer into an orientation
with different salt bridging interactions. However, the helix-
helix registrations corresponding to the apo A-IMilano and
apo A-IParis models presented in this paper are also pre-
dicted by ALIGN to be favorable interactions (Fig. 3).
Given the periodicity of the 22-mer repeats seen in the
sequence of the carboxy-terminal lipid-binding domain of
apo A-I, the existence of two cysteine mutations occurring
exactly 22 residues apart in the sequence is probably not
coincidental. As shown in Fig. 3, ALIGN predicts that a
rotation of one monomer relative to the other would produce
a favorable interhelical salt bridging pattern every 11 resi-
dues. These belt models for wild-type apo A-I, apo A-
IMilano, and apo A-IParis are dependent upon the presence of
the 11/3-helix discussed previously. In addition to these
observations, there are experimental data showing that both
apo A-IMilano and apo A-IParis form reconstituted HDL par-
ticles very similar in size and shape to reconstituted HDL
particles containing wild-type apo A-I (Calabresi et al.,
1997a; Daum et al., 1999). Calabresi et al. have shown that
reconstituted HDL particles containing a single disulfide-
linked homodimer of apo A-IMilano have diameters very
similar to those of reconstituted HDL particles containing
two monomers of wild-type apo A-I (Calabresi et al.,
1997a,b). Daum et al. (1999) have shown similar results for
apo A-IParis. The authors of both papers have also shown
that the apo A-IMilano and apo A-IParis mutations do not
affect lipid affinity or the promotion of cholesterol efflux
when compared to wild-type apo A-I. In addition, both apo
A-IMilano and apo A-IParis are capable of activating LCAT
activity, although at decreased efficiency compared to wild-
type apo A-I. Our models for wild-type apo A-I, apo A-
IMilano, and apo A-IParis are similar in their overall structure,
an observation consistent with experimental data that recon-
stituted HDL particles containing apo A-IMilano or apo A-
IParis are very similar in size and shape to reconstituted HDL
particles containing wild-type apo A-I (Calabresi et al.,
1997b; Daum et al., 1999).
Simple packing arguments favor belt models over picket
fence models. Fig. 4 shows the relationship between the
FIGURE 3 Weighted salt bridge scores of the LL docking interface. This
figure was generated using ALIGN, a modification of the HELNET pro-
gram (Jones et al., 1992; Segrest et al., 1999). The rotation coordinate (x
axis) represents the rotation of one monomer of apo A-I in the belt model
relative to the other in one-residue increments. Points along the x axis
corresponding to the helix-helix registrations for apo A-IMilano (MILANO),
apo A-IParis (PARIS), and wild-type apo A-I (WT) are labeled. The
weighted salt bridge score for each rotational orientation is indicated on the
y axis.
FIGURE 4 Alternative geometries for two monomers of the apo A-I
lipid-binding domain (residues 44–243) bound to discoidal HDLs. The
protein must cover a discoidal particle of diameter d and thickness t. A
typical small HDL has a diameter of 90–100 Å (Jonas et al., 1990) and
a hydrocarbon thickness of 30 Å (Wiener and White, 1992). The cir-
cumference is thus on the order of 300 Å, which is easily covered in the
belt model (left), because this perfectly matches an -helix containing 200
residues with a standard rise per residue of 1.5 Å. Picket fence models
contain 8–10 -helices, for which the interhelical spacing would have to be
15 Å or more to cover the circumference.
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dimensions of a discoidal HDL particle and the alternative
arrangements of apo A-I around the disk. A typical small
discoidal HDL has a diameter of 90–100 Å (Jonas et al.,
1990), with a hydrocarbon thickness of 30 Å (Wiener and
White, 1992).
Picket fence models (Tall et al., 1977; Brasseur et al.,
1990, 1992; Sparks et al., 1992; Phillips et al., 1997) with
two molecules of apo A-I and 160 molecules of POPC
(Jonas et al., 1990) are based on the observation that apo A-I
is punctuated by prolines at regular intervals, generally 22
residues, and on the assumption that prolines mark the
beginnings of -helices. With roughly 20 residues per -he-
lix and a standard rise per residue of 1.5 Å, such helices
would span the thickness of a typical bilayer quite nicely.
Unfortunately, picket fence models have only 8–10 -heli-
ces, and with a helix-helix packing distance of 10 Å
observed in crystal structures, the maximum circumference
that can be covered in the picket fence geometry is only
200 Å. Even if the water-soluble amino-terminal domain
of 43 residues is used to plug the gap, it could provide at
most two more -helices per monomer. The dimer would
then have a maximum of 24 -helices, for a circumference
of 240 Å, giving a diameter of 76 Å, which is considerably
smaller than that observed in reconstituted HDL particles
containing two monomers of wild-type apo A-I (Jonas et al.,
1990). The packing problem with picket fence models is
clearly demonstrated by figures in previously published
models (Brasseur et al., 1990, 1992; Phillips et al., 1997),
where an interhelix distance of 15 Å is required to cover
the perimeter of the disk, in at least one case leaving gaps
through which the hydrophobic lipid tails are clearly visible
(Phillips et al., 1997).
In contrast, the 200 residues of the lipid-binding domain
of apo A-I (residues 44–243) would cover the circumfer-
ence of a disk with the same stoichiometry almost perfectly
in the belt model (Segrest et al., 1999), assuming a rise per
residue of 1.5 Å for an -helix. Slightly larger diameters can
be accommodated by using the globular amino-terminal
domain to plug any gap (Segrest et al., 1999). Because each
-helix has a diameter of 10 Å, the belt is only 20 Å
across, so the bilayer is somewhat thinner at the periphery
than at the center.
Sirtori et al. have argued that the picket fence model of
apo A-I is compatible with apo A-IMilano (Sirtori et al.,
1999). The all-atom picket fence model they have published
has serious problems. First, it requires that the last 55
residues of apo A-I not associate with the lipid core, to
promote the formation of the intermolecular disulfide bridge
between residues 173 on each monomer. This appears
highly unlikely, given the fact that that the carboxy-terminal
region of apo A-I is one of the strongest lipid-binding
domains. Second, it requires an interhelical distance of 15 Å
to cover the circumference of the disk, which we believe to
be unfavorable for reasons discussed previously.
The picket fence models do not appear to explain how a
single disulfide-linked homodimer of apo A-IMilano or apo
A-IParis could form reconstituted HDL particles while still
retaining the same overall structure as reconstituted HDL
particles containing two monomers of wild-type apo A-I. As
described above, a picket fence model for apo A-IMilano
would require that a substantial portion of the lipid-binding
domain be removed from the surface of the HDL particle for
the cysteine residues to be brought into position to form a
disulfide bond. Using similar logic, we conclude that 80
residues would have to be excluded from lipid binding in
reconstituted HDL particles containing apo A-IParis to form
a disulfide-linked homodimer. This would result in recon-
stituted HDL particles containing two monomers of apo
A-IMilano with much smaller diameters than HDL particles
containing wild-type apo A-I, and reconstituted HDL par-
ticles containing two monomers of apo A-IParis would be
predicted to have even smaller diameters. Each apo A-I
mutant containing a disulfide-linked homodimer would
therefore differ dramatically in its overall structure from
wild-type apo A-I and other cysteine-containing mutants.
The belt model, however, predicts that relatively small-
scale structural rearrangements involving rotation of the
mutant apo A-I proteins, when bound to lipid, would be
sufficient to change the helix-helix registration observed in
the crystal structure to one accommodating the presence of
disulfide bonds linking the two monomers. The observation
that the apo A-IMilano and apo A-IParis mutations occur
exactly 22 residues apart in the sequence, combined with the
observation that the overall structures of reconstituted HDL
particles containing these mutants are very similar in size
and shape to that of wild-type apo A-I, provides strong
evidence in support of the belt model. The structural simi-
larity between the belt models could explain the experimen-
tal observations that the Milano and Paris mutants exhibit
rates of clearance for DMPC emulsions in vitro and choles-
terol efflux similar to those of wild-type apo A-I. This, too,
argues that there cannot be major structural differences
between the wild-type and mutant apo A-I molecules in
HDL particles.
Although the structure and activities of apo A-IMilano and
apo A-IParis are similar to those of wild-type apo A-I, their
ability to activate LCAT is decreased. It is known that the
central region of apo A-I, particularly repeat 6 (residues
143–164), is important in LCAT activation (Fielding and
Fielding, 1995). The major hypothesis of the belt model
presented by Segrest et al. argues that salt-bridging interac-
tions between helices favor the helix-helix registration ob-
served in the crystal structure over other possible registra-
tions, as shown in Fig. 3 (Segrest et al., 1999; Borhani et al.,
1997). That the disulfide-linked homodimers observed in
apo A-IMilano and apo A-IParis are effectively locked into
different helix-helix registrations suggests that the helix-
helix registration of the central domain may be crucial to the
regulation of LCAT activity.
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These models can be tested experimentally. Based upon
the structural and functional similarities between apo A-
IMilano and apo A-IParis, the 11mer periodicity observed in
the weighted salt bridge score shown in Fig. 3, and the fact
that the Milano and Paris mutations occur at the same
position on the helical wheel shown in Fig. 1, the belt model
predicts that similar mutants of apo A-I could be generated.
The substitution of a cysteine residue for any residue in the
wild-type sequence of apo A-I occurring at position 9 of the
helical wheel should generate mutants with structural and
functional properties similar to those of apo A-IMilano and
apo A-IParis. The belt model predicts that, like the Paris and
Milano mutations, these mutants would be able to form
reconstituted HDL particles containing disulfide-linked ho-
modimers of mutant apo A-I molecules with sizes and
shapes similar to those of reconstituted HDL particles con-
taining wild-type apo A-I and should show a similar ability
to clear DMPC emulsions and promote cholesterol efflux.
To form reconstituted HDL particles, the picket fence
model predicts that large-scale structural differences
would be required for each mutation and that these re-
constituted HDL particles would differ dramatically in
structure and function from reconstituted HDL particles
containing wild-type apo A-I.
Coordinates of the models are available at http://uracil.
cmc.uab.edu/Publications.
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